COLTHARP DOUGLAS E 4
4 · Encompass Health Corp · Filed May 18, 2026
Research Summary
AI-generated summary of this filing
Encompass Health (EHC) CFO Douglas Coltharp Exercises Options, Sells Shares
What Happened
- Douglas E. Coltharp, Chief Financial Officer of Encompass Health Corporation (EHC), exercised 27,694 stock options and immediately sold essentially the same number of shares on 2026-05-15. The exercise cost was $32.94 per share (27,694 shares × $32.94 = $912,240). The sales were reported as 27,693 shares sold at a weighted-average price of $106.83 (proceeds $2,958,443) and 1 share sold at $107.28 (proceeds $107), for total gross sale proceeds of $2,958,550. Net proceeds after the exercise cost were approximately $2,046,310. A related derivative line is also reported (27,694 shares at $0.00), reflecting the option exercise/settlement.
Key Details
- Transaction date: 2026-05-15; Form 4 filed: 2026-05-18 (timely filing).
- Exercise: 27,694 options exercised at $32.94 each (total cost $912,240).
- Sales: 27,693 shares sold at weighted avg $106.83 (range $106.28–$107.22 per footnote), plus 1 share at $107.28; gross proceeds ~$2.96M.
- Net proceeds (gross sales less exercise cost): ≈ $2.05M.
- Shares owned after transaction: not specified in the provided filing data.
- Footnotes: F1 — sale price is a weighted average (sales ranged $106.28–$107.22); F2 — option counts/prices were adjusted for the Enhabit, Inc. spin-off.
- Transaction codes: M = option exercise; S = sale. This pattern indicates an exercise followed by an immediate sale (a cashless or simultaneous disposition).
Context
- This is an exercise-plus-sale (option exercise with immediate sale), a common way executives realize gains and cover exercise costs or taxes. Such transactions are routine and do not necessarily indicate a change in insider sentiment.
- The filing does not indicate a 10% owner status or a 10b5‑1 trading plan in the provided data.
Insider Transaction Report
Form 4
COLTHARP DOUGLAS E
EVP & Chief Financial Officer
Transactions
- Exercise/Conversion
Encompass Health Common Stock
2026-05-15$32.94/sh+27,694$912,240→ 97,071 total - Sale
Encompass Health Common Stock
[F1]2026-05-15$106.83/sh−27,693$2,958,443→ 69,378 total - Sale
Encompass Health Common Stock
2026-05-15$107.28/sh−1$107→ 69,377 total - Exercise/Conversion
Non-qualified Stock Option (Right to Buy)
[F2]2026-05-15−27,694→ 0 totalExercise: $32.94From: 2019-10-28Exp: 2026-10-28→ Encompass Health Common Stock (27,694 underlying)
Holdings
- 27,480(indirect: By Trust)
Encompass Health Common Stock
- 125,631(indirect: By Trust)
Encompass Health Common Stock
- 37,749(indirect: By Spouse)
Encompass Health Common Stock
Footnotes (2)
- [F1]This per share price is a weighted average price. These shares were sold in multiple transactions at prices ranging from $106.28 to $107.22, inclusive. The reporting person undertakes to provide to Encompass Health Corporation, any of its security holders, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within this range.
- [F2]The exercise price and number of options reported have been adjusted, pursuant to Article 17 of the 2016 Omnibus Performance Incentive Plan, for the spin-off distribution of the common stock of Enhabit, Inc.
Signature
/s/ Patrick Darby, attorney-in-fact for Mr. Coltharp|2026-05-18